Enhancer ID: | E_02_0755 |
Species: | human |
Position : | chr13:56243248-56243833 |
Biosample name: | |
Experiment class : | Low throughput |
Enhancer type: | Enhancer |
Disease: | -- |
Pubmed ID: | 30008200 |
Enhancer experiment: | ChIP |
Enhancer experiment description: | In control cells, the enrichment of H3K27Ac, an active Enhancer marker, was significantly increased at the Neurog1 promoter, as well as other Enhancers, upon RA treatment. |
Target gene : | Neurog1(AKA,Math4C,Neurod3,bHLHa6,ngn1) |
Strong evidence: | -- |
Less strong evidence: | ChIP-qPCR |
Target gene experiment description: | Genome-wide CTCF occupancy patterns, which have been mapped across more than 100 mammalian cell types, re_x0002_vealed prominent CTCF binding to the -14.4 kb and -7.6 kb transcription start sites of Neurog1.We performed ChIP-qPCR analysis to validate the in vivo binding of CTCF in P19 cells, and observed strong occupancy of CTCF to these binding sites. |
TF name : | Ctcf(MRD21) |
TF experiment: | ChIP-qPCR |
TF experiment description: | Genome-wide CTCF occupancy patterns, which have been mapped across more than 100 mammalian cell types, re_x0002_vealed prominent CTCF binding to the -14.4 kb and -7.6 kb transcription start sites of Neurog1.We performed ChIP-qPCR analysis to validate the in vivo binding of CTCF in P19 cells, and observed strong occupancy of CTCF to these binding sites. |
Enhancer function : | -- |
Enhancer function experiment: | -- |
Enhancer function experiment description: |
-- |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|---|---|---|
Ctcf | Activation of anterior HOX genes in hindbrain development during early embryogenesis | reactome | 120 |
Ctcf | TGF_beta_Receptor | netpath | 220 |